A stable gene set for prediction of prognosis and efficacy of chemotherapy in gastric cancer
Abstract Background Gastric cancer (GC) is a primary reason for cancer death in the world. At present, GC has become a public health issue urgently to be solved to. Prediction of prognosis is critical to the development of clinical treatment regimens. This work aimed to construct the stable gene set...
Main Authors: | Rui Wu, Sixuan Guo, Shuhui Lai, Guixing Pan, Linyi Zhang, Huanbing Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-08444-w |
Similar Items
-
Establishment of an Immune Cell Infiltration Score to Help Predict the Prognosis and Chemotherapy Responsiveness of Gastric Cancer Patients
by: Quan Jiang, et al.
Published: (2021-07-01) -
Platelet-to-lymphocyte ratio and lymphocyte-to-white blood cell ratio predict the efficacy of neoadjuvant chemotherapy and the prognosis of locally advanced gastric cancer patients treated with the oxaliplatin and capecitabine regimen
by: Tang C, et al.
Published: (2018-10-01) -
Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer
by: Jun Lu, et al.
Published: (2019-09-01) -
Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer
by: Ran Duan, et al.
Published: (2021-01-01) -
Prognosis of Poorly-differentiated Gastric Neuroendocrine Neoplasm
by: ZHANG Jian, et al.
Published: (2019-05-01)